392 related articles for article (PubMed ID: 17208328)
1. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
Rollin J; Régina S; Vourc'h P; Iochmann S; Bléchet C; Reverdiau P; Gruel Y
Lung Cancer; 2007 May; 56(2):273-80. PubMed ID: 17208328
[TBL] [Abstract][Full Text] [Related]
2. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
[TBL] [Abstract][Full Text] [Related]
3. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531
[TBL] [Abstract][Full Text] [Related]
4. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer.
Yu C; Zhou Y; Miao X; Xiong P; Tan W; Lin D
Cancer Res; 2004 Oct; 64(20):7622-8. PubMed ID: 15492291
[TBL] [Abstract][Full Text] [Related]
5. A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer.
Xu E; Lai M; Lv B; Xing X; Huang Q; Xia X
Biochem Biophys Res Commun; 2004 Nov; 324(3):999-1003. PubMed ID: 15485653
[TBL] [Abstract][Full Text] [Related]
6. [Study on the association of SNPs of MMP-2 and TIMP-2 genes with the risk of endometriosis and adenomyosis].
Zhao XW; Li Y; Wang N; Zhao J; Li XL; Liu Q; Jia JH; Yang ZF; Kang S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):280-3. PubMed ID: 18543216
[TBL] [Abstract][Full Text] [Related]
7. A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.
Vasků A; Goldbergová M; Izakovicová Hollá L; Sisková L; Groch L; Beránek M; Tschöplová S; Znojil V; Vácha J
Matrix Biol; 2004 Jan; 22(7):585-91. PubMed ID: 14996438
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype.
Grieu F; Li WQ; Iacopetta B
Breast Cancer Res Treat; 2004 Dec; 88(3):197-204. PubMed ID: 15609121
[TBL] [Abstract][Full Text] [Related]
9. Gene polymorphisms of matrix metalloproteinase-2, -9 and -12 in periodontal health and severe chronic periodontitis.
Gürkan A; Emingil G; Saygan BH; Atilla G; Cinarcik S; Köse T; Berdeli A
Arch Oral Biol; 2008 Apr; 53(4):337-45. PubMed ID: 18155181
[TBL] [Abstract][Full Text] [Related]
10. Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
Safranek J; Pesta M; Holubec L; Kulda V; Dreslerova J; Vrzalova J; Topolcan O; Pesek M; Finek J; Treska V
Anticancer Res; 2009 Jul; 29(7):2513-7. PubMed ID: 19596921
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China.
Fang S; Jin X; Wang R; Li Y; Guo W; Wang N; Wang Y; Wen D; Wei L; Zhang J
Carcinogenesis; 2005 Feb; 26(2):481-6. PubMed ID: 15528217
[TBL] [Abstract][Full Text] [Related]
12. Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility.
Zhou Y; Yu C; Miao X; Wang Y; Tan W; Sun T; Zhang X; Xiong P; Lin D
Carcinogenesis; 2005 Jun; 26(6):1117-21. PubMed ID: 15731163
[TBL] [Abstract][Full Text] [Related]
13. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
Zhang J; Jin X; Fang S; Wang R; Li Y; Wang N; Guo W; Wang Y; Wen D; Wei L; Dong Z; Kuang G
Carcinogenesis; 2005 Oct; 26(10):1748-53. PubMed ID: 15930031
[TBL] [Abstract][Full Text] [Related]
14. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Chen W; Chang GC; Chou MC; Lin LY
Lung Cancer; 2006 Apr; 52(1):15-20. PubMed ID: 16476505
[TBL] [Abstract][Full Text] [Related]
15. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Hsu WF; Chen WE; Chou MC; Lin LY
Lung Cancer; 2005 Dec; 50(3):291-7. PubMed ID: 16122836
[TBL] [Abstract][Full Text] [Related]
16. [Association of functional polymorphisms in matrix metalloproteinase-2 (MMP-2) and MMP-9 genes with risk of gastric cancer in a Chinese population].
Zhang XM; Miao XP; Xiong P; Yu CY; Tan W; Qu SN; Sun T; Zhou YF; Lin DX
Ai Zheng; 2004 Nov; 23(11):1233-7. PubMed ID: 15522165
[TBL] [Abstract][Full Text] [Related]
17. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.
O-Charoenrat P; Khantapura P
Oral Oncol; 2006 Mar; 42(3):257-67. PubMed ID: 16275157
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma.
Herbst RS; Yano S; Kuniyasu H; Khuri FR; Bucana CD; Guo F; Liu D; Kemp B; Lee JJ; Hong WK; Fidler IJ
Clin Cancer Res; 2000 Mar; 6(3):790-7. PubMed ID: 10741698
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer.
Zinzindohoué F; Lecomte T; Ferraz JM; Houllier AM; Cugnenc PH; Berger A; Blons H; Laurent-Puig P
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):594-9. PubMed ID: 15701845
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin's lymphoma.
Diao LP; Ma H; Wei GC; Li T; Liu HS; Liu LH; Wu LL; Zhao GM; Gao YH
Int J Cancer; 2012 Sep; 131(5):1095-103. PubMed ID: 22020421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]